|
|
|
Volumn 20, Issue 3, 2010, Pages 315-321
|
|
Effects of SERMs on bone health. Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BONE DENSITY CONSERVATION AGENT;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
BONE;
BONE DENSITY;
EVIDENCE BASED MEDICINE;
HUMAN;
METABOLISM;
PATHOLOGIC FRACTURE;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
BONE AND BONES;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
EVIDENCE-BASED MEDICINE;
FRACTURES, SPONTANEOUS;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
|
EID: 77952978615
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (14)
|
